These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 28415824)
1. Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma. Chen Z; Pu L; Gao W; Zhang L; Han G; Zhu Q; Li X; Wu J; Wang X Oncotarget; 2017 Apr; 8(17):28959-28970. PubMed ID: 28415824 [TBL] [Abstract][Full Text] [Related]
2. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study. Liao P; Cao L; Chen H; Pang SZ Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742 [TBL] [Abstract][Full Text] [Related]
3. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma. Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927 [TBL] [Abstract][Full Text] [Related]
4. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre. Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093 [TBL] [Abstract][Full Text] [Related]
5. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma. Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893 [TBL] [Abstract][Full Text] [Related]
6. SOX4 is associated with poor prognosis in cholangiocarcinoma. Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339 [TBL] [Abstract][Full Text] [Related]
7. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma. Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486 [TBL] [Abstract][Full Text] [Related]
8. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330 [TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients. Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940 [TBL] [Abstract][Full Text] [Related]
10. The DNA index as a prognostic tool in hilar cholangiocarcinoma. Kamphues C; Al-Abadi N; Bova R; Rademacher S; Al-Abadi H; Klauschen F; Bahra M; Neuhaus P; Pratschke J; Seehofer D J Surg Oncol; 2015 Aug; 112(2):214-8. PubMed ID: 26220797 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of site-specific metastases for patients with advanced intrahepatic cholangiocarcinoma: A SEER database analysis. Cheng R; Du Q; Ye J; Wang B; Chen Y Medicine (Baltimore); 2019 Dec; 98(49):e18191. PubMed ID: 31804337 [TBL] [Abstract][Full Text] [Related]
12. The current management of hilar cholangiocarcinoma. Jarnagin WR; Fong Y; Blumgart LH Adv Surg; 1999; 33():345-73. PubMed ID: 10572576 [No Abstract] [Full Text] [Related]
14. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573 [TBL] [Abstract][Full Text] [Related]
15. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis. Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768 [TBL] [Abstract][Full Text] [Related]
16. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors? Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704 [TBL] [Abstract][Full Text] [Related]
17. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196 [TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology. Kaneko R; Sato Y; Kobayashi Y J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416 [TBL] [Abstract][Full Text] [Related]
19. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199 [TBL] [Abstract][Full Text] [Related]
20. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]